Cargando…
Handlungsempfehlung zur Therapieumstellung von Immunsuppressiva auf Dupilumab bei Patienten mit atopischer Dermatitis
Based on new insights into the molecular pathogenesis of atopic dermatitis, a targeted anti-inflammatory therapy—dupilumab—has recently been approved as treatment alongside glucocorticoids and ciclosporin. Due to their pharmacology, neither glucocorticoids nor ciclosporin nor the off label used subs...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016796/ https://www.ncbi.nlm.nih.gov/pubmed/33175219 http://dx.doi.org/10.1007/s00105-020-04720-1 |